<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2017-1-47-52</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-353</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL &amp; EXPERIMENTAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Отдаленные клинико-функциональные результаты хирургического лечения неоваскулярной глаукомы с применением дренажа «Глаутекс» и клапана Ahmed</article-title><trans-title-group xml:lang="en"><trans-title>Long-term Clinical and Functional Results of Neovascular Glaucoma Surgical Treatment with Glautex Drainage and Ahmed Valve</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бикбов</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bikbov</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, директор,</p><p>ул. Пушкина, 90, г. Уфа, Башкортостан, 450008</p></bio><bio xml:lang="en"><p>MD, prof., Head of Ufa Eye Research Institute,</p><p>Pushkina str., 90, Ufa, Republic of Bashkortostan, 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хуснитдинов</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Khusnitdinov</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., заведующий II микрохирургическим отделением,</p><p>ул. Пушкина, 90, г. Уфа, Башкортостан, 450008</p></bio><bio xml:lang="en"><p>PhD, Head of the II Microsurgical Department Ufa Eye Research Institute,</p><p>Pushkina str., 90, Ufa, Republic of Bashkortostan, 450008</p></bio><email xlink:type="simple">husnitdinov.ilnu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУ «Уфимский НИИ глазных болезней Академии наук Республики Башкортостан»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ufa Eye Research Institute of Academy of Sciences of the Republic of Bashkortostan</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>29</day><month>03</month><year>2017</year></pub-date><volume>14</volume><issue>1</issue><fpage>47</fpage><lpage>52</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бикбов М.М., Хуснитдинов И.И., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Бикбов М.М., Хуснитдинов И.И.</copyright-holder><copyright-holder xml:lang="en">Bikbov M.M., Khusnitdinov I.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/353">https://www.ophthalmojournal.com/opht/article/view/353</self-uri><abstract><p>Цель — проанализировать эффективность фистулизирующих операций с дренажом «Глаутекс» и имплантацией клапана Ahmed при неоваскулярной глаукоме в течение 3 лет.</p><sec><title>Пациенты и методы</title><p>Пациенты и методы. Под наблюдением находилось 44 пациента (44 глаз) с вторичной неоваскулярной глаукомой на фоне посттромботической и пролиферативной диабетической ретинопатии. Возраст пациентов в среднем составил 60,84±1,29 лет, мужчин — 19, женщин — 25. В зависимости от применяемых дренажей и дренажных устройств пациенты были разделены на две группы. В I группе выполняли стандартную синустрабекулэктомию с дренажом «Глаутекс» у 23 пациентов. Во II группу вошли 21 пациент, которым имплантировали клапан Ahmed.</p></sec><sec><title>Результаты</title><p>Результаты. По результатам нашего исследования относительный гипотензивный эффект составил в I и II группе, соответственно, 52,2% (12/23) и 79,4% (17/21) через 1 год после операции; 43,5% (10/23) и 71,4% (15/21) — через 2 года; 39,1% (9/23) и 66,7% (14/21) — че- рез 3 года наблюдения. Максимальное снижение ВГД в анализируемых группах отмечалось непосредственно после операции на 66,8% и 64,5%, соответственно. Отсутствие эффекта от хирургического лечения в течение 3-х лет зафиксировано в I группе в 60,8% (14/23), во II группе — в 33,3% (7/21) случаев.</p></sec><sec><title>Заключение</title><p>Заключение. Проведенный анализ клинико-функциональных результатов хирургического лечения пациентов с неоваскулярной глаукомой в сроки наблюдения до 3 лет показал, что наиболее продолжительное сохранение зрительных функций и гипотензивного эффекта было достигнуто после имплантации клапана Ahmed (66,7% случаев). При синустрабекулэктомии с дренажом «Глаутекс» эффект получен в 39,1% случаев. Частота развития послеопера- ционных осложнений в обеих группах была сопоставима: так, гифема, гипотония и прорезывание имплантов появились после синустрабекулэктомии с дренажом «Глаутекс» в 26,1%, 21,7% и 4,3% случаев, соответственно, а после имплантации клапана Ahmed — в 23,8%, 19,1% и в 9,6% случаев. </p></sec></abstract><trans-abstract xml:lang="en"><p>Purpose — to determine the effect of fistulizing operations with Glautex drainage and Ahmed valve implantation in the cases with neovascular glaucoma within 3 years.</p><sec><title>Patients and methods</title><p>Patients and methods. We observed 44 patients (44 eyes) with secondary neovascular glaucoma on the background of post-thrombotic and proliferative diabetic retinopathy. Patient age averaged 60,84±1,29 years. Males — 19, females — 25. The patients were divided into two groups depending on the used drainages and drainage devices. In Group I the standard sinus trabeculectomy with Glautex drainage was performed in 23 patients. The II group included 21 patients who were implanted Ahmed valve.</p></sec><sec><title>Results</title><p>Results. According to the results of our research the relative hypotensive effect was in groups I and II, respectively, 52.2% (12/23) and 79.4% (17/21) 1 year after surgery; 43.5% (10/23) and 71.4% (15/21) — 2 years after surgery; 39.1% (9/23) and 66.7% (14/21) — after 3 years of follow up. The maximum decrease in IOP was observed immediately after surgery in the analyzed groups, 66.8% and 64.5%, respectively. There was no surgical treatment effect for 3 years in Group I in 60.8% (14/23), in group II — 33.3% (7/21) of the cases.</p></sec><sec><title>Conclusion</title><p>Conclusion. The analysis of clinical and functional results of surgical treatment of patients with neovascular glaucoma in terms of 3 years follow up showed that the most lasting preservation of visual function and the hypotensive effect was achieved after implantation of the Ahmed valve — in 66.7% of the cases. In the cases of sinus trabeculectomy with Glautex drainage — in 39.1% of the cases. The incidence of postoperative complications in both groups was comparable: as hyphema, hypotension, and the eruption of implants developed after sinus trabeculectomy with Glautex drainage in 26.1%, 21.7% and 4.3%, respectively, after Ahmed valve implantation in 23 8%, 19.1% and 9.6% of the cases.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>неоваскулярная глаукома</kwd><kwd>синустрабекулэктомия</kwd><kwd>дренажная хирургия глаукомы</kwd><kwd>дренаж «Глаутекс»</kwd><kwd>клапан Ahmed</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neovascular glaucoma</kwd><kwd>glaucoma drainage surgery</kwd><kwd>Glautex drainage</kwd><kwd>Ahmed valve</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bessmertnyy A.M., Chervyakov A.Yu. [The use of implants in treatment of refractory glaucoma]. Primenenie implantatov v lechenii refrakternoy glaukomy. [Glaukoma]. Glaukoma. 2001;1:44-41. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Bessmertnyy A.M., Chervyakov A.Yu. [The use of implants in treatment of refractory glaucoma]. Primenenie implantatov v lechenii refrakternoy glaukomy. [Glaukoma]. Glaukoma. 2001;1:44-41. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bettin P., Di Matteo F. Glaucoma: present challenges and future trends. Ophthalmic Res. 2013;50(4):197-208. DOI: 10.1159/000348736.</mixed-citation><mixed-citation xml:lang="en">Bettin P., Di Matteo F. Glaucoma: present challenges and future trends. Ophthalmic Res. 2013;50(4):197-208. DOI: 10.1159/000348736.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gheith M.E., Mayer J.R., Siam G.A. et al. Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%). Clin. Ophthalmol. 2008;2(1):15-20.</mixed-citation><mixed-citation xml:lang="en">Gheith M.E., Mayer J.R., Siam G.A. et al. Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%). Clin. Ophthalmol. 2008;2(1):15-20.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Horsley MB, Kahook MY. Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol. 2010;21(2):112-117. DOI: 10.1097/ICU.0b013e3283360aad.</mixed-citation><mixed-citation xml:lang="en">Horsley MB, Kahook MY. Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol. 2010;21(2):112-117. DOI: 10.1097/ICU.0b013e3283360aad.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108(10):1767-1776; quiz1777, 1800.</mixed-citation><mixed-citation xml:lang="en">Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108(10):1767-1776; quiz1777, 1800.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shen C.C., Salim S., Du H., Netland P.A. Trabeculotomy versus Ahmed Glaucoma Valve implantation in neovascularglaucoma. Clin Ophthalmol. 2011;5:281-286. DOI: 10.5005/jp-journals-10008-1203</mixed-citation><mixed-citation xml:lang="en">Shen C.C., Salim S., Du H., Netland P.A. Trabeculotomy versus Ahmed Glaucoma Valve implantation in neovascularglaucoma. Clin Ophthalmol. 2011;5:281-286. DOI: 10.5005/jp-journals-10008-1203</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Avanesova T.A., Gur'eva N.V., Zhavoronkov S.A., Oleynik A.I., Egorov E.A. [Experience of Ahmed valve drainage usage in surgical treatment of refractory glaucoma]. Opyt primeneniya drenazhey Ahmed v khirurgicheskom lechenii refrakternoy glaukomy. [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2010;2:55-58. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Avanesova T.A., Gur'eva N.V., Zhavoronkov S.A., Oleynik A.I., Egorov E.A. [Experience of Ahmed valve drainage usage in surgical treatment of refractory glaucoma]. Opyt primeneniya drenazhey Ahmed v khirurgicheskom lechenii refrakternoy glaukomy. [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2010;2:55-58. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bikbov M.M., Surkova V.K., Khusnitdinov I.I., Chayka O.V., Orenburkina O.I., Dzhamantaeva Sh.D. [Results of implantation of drenaige system Ahmed in patients with refractory glaucoma]. Rezul'taty primeneniya drenazha Ahmed pri refrakternoy glaukome. [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2013;3:98-101. (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Bikbov M.M., Surkova V.K., Khusnitdinov I.I., Chayka O.V., Orenburkina O.I., Dzhamantaeva Sh.D. [Results of implantation of drenaige system Ahmed in patients with refractory glaucoma]. Rezul'taty primeneniya drenazha Ahmed pri refrakternoy glaukome. [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2013;3:98-101. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Budenz D, Barton K, Feuer W, Schiffman J, Costa V, Godfrey D, Buys YM. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology. 2011;118:443–452. DOI: 10.1016/j.ophtha.2010.07.016.</mixed-citation><mixed-citation xml:lang="en">Budenz D, Barton K, Feuer W, Schiffman J, Costa V, Godfrey D, Buys YM. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology. 2011;118:443–452. DOI: 10.1016/j.ophtha.2010.07.016.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bikbov M.M., Surkova V.K., Khusnitdinov I.I., Orenburkina O.I., Chayka O.V. [The outcomes of refractory glaucoma surgery using collagen bio-implant]. Rezul'taty khirurgicheskogo lecheniya refrakternoy glaukomy s ispol'zovaniem kollagenovogo biodrenazha. [Ophthalmology in Russia]. Oftal'mologiya. 2014;11(2):55-58. (in Russ.). DOI: http://dx.doi.org/10.18008/1816-5095-2014-2-55-58</mixed-citation><mixed-citation xml:lang="en">Bikbov M.M., Surkova V.K., Khusnitdinov I.I., Orenburkina O.I., Chayka O.V. [The outcomes of refractory glaucoma surgery using collagen bio-implant]. Rezul'taty khirurgicheskogo lecheniya refrakternoy glaukomy s ispol'zovaniem kollagenovogo biodrenazha. [Ophthalmology in Russia]. Oftal'mologiya. 2014;11(2):55-58. (in Russ.). DOI: http://dx.doi.org/10.18008/1816-5095-2014-2-55-58</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lima F, Magacho L, Carvalho D, Susanna R, Avila M. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. 2004;13:233–237.</mixed-citation><mixed-citation xml:lang="en">Lima F, Magacho L, Carvalho D, Susanna R, Avila M. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. 2004;13:233–237.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Prokof 'eva M.I. [Modern surgical approaches to refractory glaucoma treatment. (Literary revive)]. Sovremennye khirurgicheskie podkhody k lecheniyu refrakternoy glaukomy (obzor literatury). [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2010;11(3):104-108. (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Prokof 'eva M.I. [Modern surgical approaches to refractory glaucoma treatment. (Literary revive)]. Sovremennye khirurgicheskie podkhody k lecheniyu refrakternoy glaukomy (obzor literatury). [Clinical Ophthalmology]. Klinicheskaya oftal'mologiya. 2010;11(3):104-108. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Coleman A, Hill R, Wilson M. et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995;120:23–31.</mixed-citation><mixed-citation xml:lang="en">Coleman A, Hill R, Wilson M. et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995;120:23–31.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Slonimskiy A.Yu., Alekseev I.B., Dolgiy S.S., Korigodskiy A.R. [New biodegradable drainage “Glautex” in the surgical treatment of glaucoma]. Novyy biodegradiruemyy drenazh «Glauteks» v khirurgicheskom lechenii glaukomy. [National Journal glaucoma]. Natsional'nyy zhurnal glaukoma. 2012;4:55-59. (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Slonimskiy A.Yu., Alekseev I.B., Dolgiy S.S., Korigodskiy A.R. [New biodegradable drainage “Glautex” in the surgical treatment of glaucoma]. Novyy biodegradiruemyy drenazh «Glauteks» v khirurgicheskom lechenii glaukomy. [National Journal glaucoma]. Natsional'nyy zhurnal glaukoma. 2012;4:55-59. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Papadaki T, Zacharopoulos I, Pasquale L, Christen W, Netland P, Foster CS. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62-69. DOI:10.1016/j.ajo.2007.03.013</mixed-citation><mixed-citation xml:lang="en">Papadaki T, Zacharopoulos I, Pasquale L, Christen W, Netland P, Foster CS. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62-69. DOI:10.1016/j.ajo.2007.03.013</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Souza C, Tran DH, Loman J, et al. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol. 2007;144:893-900. DOI:10.1016/j.ajo.2007.07.035</mixed-citation><mixed-citation xml:lang="en">Souza C, Tran DH, Loman J, et al. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol. 2007;144:893-900. DOI:10.1016/j.ajo.2007.07.035</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H, Yang Y, Xu Y, Yang R, Wang B, Hu J. Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma. Int J Ophthalmol. 2014 Oct 18;7(5):837-842. DOI: 10.3980/j.issn.22223959.2014.05.18. eCollection 2014.</mixed-citation><mixed-citation xml:lang="en">Zhang H, Yang Y, Xu Y, Yang R, Wang B, Hu J. Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma. Int J Ophthalmol. 2014 Oct 18;7(5):837-842. DOI: 10.3980/j.issn.22223959.2014.05.18. eCollection 2014.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou M, Wang W, Huang W, Chen S, Li X, Gao X, Zhang X. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J (Engl). 2013;126(8):1412-1417.</mixed-citation><mixed-citation xml:lang="en">Zhou M, Wang W, Huang W, Chen S, Li X, Gao X, Zhang X. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J (Engl). 2013;126(8):1412-1417.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Eid T, Radwan A, El-Manawy W, El-Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol. 2009;44(4):451–456. DOI: 10.3129/i09-108.</mixed-citation><mixed-citation xml:lang="en">Eid T, Radwan A, El-Manawy W, El-Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol. 2009;44(4):451–456. DOI: 10.3129/i09-108.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sahyoun M, Azar G, Khoueir Z, Antoun J, Kourie H, Nehme J, Jalkh A. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma. J Glaucoma. 2015; 24(5):383-388. DOI: 10.1097/IJG.0000000000000234.</mixed-citation><mixed-citation xml:lang="en">Sahyoun M, Azar G, Khoueir Z, Antoun J, Kourie H, Nehme J, Jalkh A. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma. J Glaucoma. 2015; 24(5):383-388. DOI: 10.1097/IJG.0000000000000234.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
